Next Article in Journal
Glycosylated Receptor-Binding-Domain-Targeting Mucosal Vaccines Protect Against SARS-CoV-2 Omicron and MERS-CoV
Previous Article in Journal
Prime-Boost Vaccination Based on Nanospheres and MVA Encoding the Nucleoprotein of Crimean-Congo Hemorrhagic Fever Virus Elicits Broad Immune Responses
 
 
Review

Article Versions Notes

Vaccines 2025, 13(3), 292; https://doi.org/10.3390/vaccines13030292
Action Date Notes Link
article xml file uploaded 10 March 2025 10:33 CET Original file -
article xml uploaded. 10 March 2025 10:33 CET Update https://www.mdpi.com/2076-393X/13/3/292/xml
article pdf uploaded. 10 March 2025 10:33 CET Version of Record https://www.mdpi.com/2076-393X/13/3/292/pdf
article html file updated 10 March 2025 10:35 CET Original file https://www.mdpi.com/2076-393X/13/3/292/html
Back to TopTop